Tybost
NDC 61958-1401 · Gilead Sciences, Inc.
Generic nameCOBICISTAT
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)COBICISTAT
Strength150 mg/1
Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing categoryNDA
Packages
61958-1401-1 — 30 TABLET, FILM COATED in 1 BOTTLE (61958-1401-1)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0003-3641 — atazanavir and cobicistat, 50090-1723 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-575 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-577 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-578 — DARUNAVIR ETHANOLATE and COBICISTAT, 59676-800 — Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 61958-1901 — elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide